Design of antiviral stapled peptides containing a biphenyl cross-linker.
暂无分享,去创建一个
[1] A. Debnath,et al. Dual-acting stapled peptides target both HIV-1 entry and assembly , 2013, Retrovirology.
[2] Hong-Gang Wang,et al. Rational design of proteolytically stable, cell-permeable peptide-based selective Mcl-1 inhibitors. , 2012, Journal of the American Chemical Society.
[3] Young Do Kwon,et al. Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops , 2012, Proceedings of the National Academy of Sciences.
[4] Jiandong Chen,et al. Conjugation of spermine enhances cellular uptake of the stapled peptide-based inhibitors of p53-Mdm2 interaction. , 2011, Bioorganic & medicinal chemistry letters.
[5] Jiandong Chen,et al. Achieving cell penetration with distance-matching cysteine cross-linkers: a facile route to cell-permeable peptide dual inhibitors of Mdm2/Mdmx. , 2011, Chemical communications.
[6] J. Sodroski,et al. Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. , 2008, Structure.
[7] A. Debnath,et al. A cell-penetrating helical peptide as a potential HIV-1 inhibitor. , 2008, Journal of molecular biology.
[8] G. Verdine,et al. The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members , 2007, Clinical Cancer Research.
[9] Asim Kumar Debnath,et al. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. , 2005, Virology.
[10] Lynn Morris,et al. Recommendations for the Design and Use of Standard Virus Panels To Assess Neutralizing Antibody Responses Elicited by Candidate Human Immunodeficiency Virus Type 1 Vaccines , 2005, Journal of Virology.
[11] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[12] Hans-Georg Kräusslich,et al. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor , 2005, Nature Structural &Molecular Biology.
[13] Barbara Müller,et al. A peptide inhibitor of HIV-1 assembly in vitro , 2005, Nature Structural &Molecular Biology.
[14] A. Hamilton,et al. Strategies for targeting protein-protein interactions with synthetic agents. , 2005, Angewandte Chemie.
[15] Zheng Yang,et al. Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions. , 2003, Journal of medicinal chemistry.
[16] G. Verdine,et al. An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .
[17] Helen E Blackwell,et al. Highly Efficient Synthesis of Covalently Cross-Linked Peptide Helices by Ring-Closing Metathesis. , 1998, Angewandte Chemie.